Vividion Therapeutics

Vividion Therapeutics

Vividion Therapeutics

Vividion is a biotech company applying transformational proteomics to develop innovative therapeutics that treat major unmet clinical needs.
Raised
$132M
Follow us
Latest funding
$82,000,000
Venture capital (Series B) - 2019
Cardinal Partners Celgene Versant Ventures +7
$50,000,000
Venture capital (Series A) - 2017
ARCH Venture Partners Versant Ventures
Team Size
1–10
Employees
PE HUB

Vividion Therapeutics picks up $50 mln Series A

Funding Messaging
$50,000,000 Venture capital (Series A)
businesswire

Vividion Therapeutics, Inc., Launches With $50 Million Series A Financing